Arecor Limited: Clinical Trials

4 trials sponsored by Arecor Limited, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Arecor Limited: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study
AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution - Diabetes Mellitus, Type 2
Phase 1CompletedArecor Limited412023-02-272024-02-16
AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study
AT247, NovoLog, Fiasp - Diabetes Mellitus, Type 1
Phase 1CompletedArecor Limited242022-01-032022-09-13
AT278 and NovoRapid® in Glucose Clamp Study
AT278, NovoRapid - Diabetes Mellitus, Type 1
Phase 1CompletedArecor Limited382020-12-022021-07-21
AT247, NovoRapid® and Fiasp® in Glucose Clamp Study
NovoRapid, Fiasp, AT247 - Diabetes Mellitus, Type 1
Phase 1CompletedArecor Limited182019-04-122019-09-30

Conditions studied

Diabetes Mellitus, Type 1 (3)  ·  Diabetes Mellitus, Type 2 (1)

Interventions

Insulin Aspart (4)

Countries

Austria (3)  ·  United States (1)

Results publications

PMID 33328285, PMID 42530378